Cellular models and therapies for age-related macular degeneration. - Wikidata - awgldk - TriplyDB

Cellular models and therapies for age-related macular degeneration.

Cellular models and therapies for age-related macular degeneration.

http://www.wikidata.org/entity/Q35558042

about

In Vitro Cell Models for Ophthalmic Drug Development Applications The Endocannabinoid System in the Retina: From Physiology to Practical and Therapeutic Applications Norbixin Protects Retinal Pigmented Epithelium Cells and Photoreceptors against A2E-Mediated Phototoxicity In Vitro and In Vivo Long-Term Efficacy of GMP Grade Xeno-Free hESC-Derived RPE Cells Following Transplantation.The inhibition of NOTCH2 reduces UVB-induced damage in retinal pigment epithelium cells.Ultrathin Polyimide Membrane as Cell Carrier for Subretinal Transplantation of Human Embryonic Stem Cell Derived Retinal Pigment Epithelium In Pursuit of Authenticity: Induced Pluripotent Stem Cell-Derived Retinal Pigment Epithelium for Clinical Applications.A basis for comparison: sensitive authentication of stem cell derived RPE using physiological responses of intact RPE monolayers.Pluripotent stem cells progressing to the clinic.Dry Age-Related Macular Degeneration Pharmacology.From bench to patient: model systems in drug discovery HtrA1 activation is driven by an allosteric mechanism of inter-monomer communication.Nicotinamide: a novel treatment for age-related macular degeneration?The effects of platelet gel on cultured human retinal pigment epithelial (hRPE) cells.A model to study complement involvement in experimental retinal degeneration.

P2860

Q26751148-A8A6F900-A027-42F6-9C69-06AA2A9A4642 Q26765747-C7C50E2B-F36F-44DF-998C-98DCC9BE6A16 Q28555093-D822EBAF-4D15-4A6B-915E-44B24553B4EC Q33803526-E69ED9A7-87AB-44EE-B714-6175BBB69F97 Q33828306-4C953B41-603C-444A-9F97-844257E18C5D Q35852620-BB49C77A-7CCD-4283-BE8A-32050B2D5B43 Q37350710-60CD193E-E184-49EC-9803-85242053BF22 Q37686695-AC42F57B-C347-4238-9FBD-1C1A682CC46F Q38747535-EE62DC2B-8D3A-4D12-975C-AA750A1D77E3 Q38789140-7780E66D-5D54-4C65-AA07-3CFB038D29E3 Q42593469-7A39D97B-0B16-439E-90AC-307937939539 Q43632795-5831A9E7-E9E6-484B-BF68-1D7778A73896 Q47098865-E031D5CC-A256-401F-961E-62EEF47E844D Q47134985-951AA49E-DEB4-41F9-847C-93679F8D90FC Q50046723-1F45A864-A86D-4081-8DC7-91DBBD98FDEC

P2860

Cellular models and therapies for age-related macular degeneration.

http://www.wikidata.org/entity/Q35558042

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Cellular models and therapies for age-related macular degeneration.

@ast

Cellular models and therapies for age-related macular degeneration.

@en

type

label

Cellular models and therapies for age-related macular degeneration.

@ast

Cellular models and therapies for age-related macular degeneration.

@en

prefLabel

Cellular models and therapies for age-related macular degeneration.

@ast

Cellular models and therapies for age-related macular degeneration.

@en

P1433

Q35558042-B9D72D37-F532-412E-9DF2-69C9CD7CBCEC

P1476

Q35558042-EBBA25EC-EB80-42DE-8B27-E9958138035D

P2093

Q35558042-000ED5E8-E8C2-48B2-A251-AFB19F69F851

Q35558042-39D56B1C-2E23-49F2-8E18-9A13EFFF210A

Q35558042-F60BE8B5-5443-4D6B-8DD9-34430D83F4A0

P275

Q35558042-5F5FAA84-C68E-41A7-B7AB-D36FA7DC70D2

P2860

Q35558042-04AAF1EA-A3BA-4036-86F7-574FDED1420A

Q35558042-0836747B-43B0-4C48-83E2-43AB03125667

Q35558042-11054F67-D27E-459E-BE12-796EE1423FCB

Q35558042-1B23CBB6-AC78-4A53-8D42-056CB65141D8

Q35558042-22ADD658-24BB-48D0-9454-377E3F96E6DC

Q35558042-2335EDF7-674E-4B95-B16C-D17FAA6981A1

Q35558042-2A0CD541-AA19-4C79-9CAD-9F73FB86B81D

Q35558042-2FD6DFA8-25B6-4C67-9FB1-513A5CC576DA

Q35558042-32DC2112-901B-4DCA-9979-C6DC12781E86

Q35558042-341A91A5-A7A6-4D26-9A6D-53E3CFB1BF26

P304

Q35558042-D523BD2B-36FD-41B9-8F27-1512E8E18D41

P31

Q35558042-882B58C3-68CC-4F39-AD8A-BB279F69B537

Q35558042-CEEF9F7F-336A-4E49-8940-63957E6DB015

P356

Q35558042-63059727-2250-4014-9325-ECB9BB8278E0

P433

Q35558042-2B58B524-A5D5-4F50-B568-A47121ED4081

P478

Q35558042-016E8A44-6075-4DD1-A22F-548BFD916E97

P5008

Q35558042-088F8C36-A329-4038-875F-1AEDC656D5AD

P577

Q35558042-882A51B9-71A5-4CC1-9F08-34651C4F56D9

P5875

Q35558042-7E81AEE9-082E-4367-BD36-1B61F049BAA5

P698

Q35558042-7357859E-F6FC-4C18-9463-2BC96665D503

P921

Q35558042-81F6BD42-5817-479F-AA2B-6784804DC454

Q35558042-86E23839-C87A-49CA-B868-6F746DCD393D

P932

Q35558042-38D24284-4EA3-4EE2-9F86-8B5D17772F6D

P356

P1433

Disease Models & Mechanisms

P1476

Cellular models and therapies for age-related macular degeneration.

@en

P2093

David L Forest

http://www.w3.org/2001/XMLSchema#string

Dennis O Clegg

http://www.w3.org/2001/XMLSchema#string

Lincoln V Johnson

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 3.0 Unported

P2860

A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration

Switching cell fate: the remarkable rise of induced pluripotent stem cells and lineage reprogramming technologies

Animal models of age related macular degeneration

Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors

Embryonic stem cell lines derived from human blastocysts

Long-term safety and function of RPE from human embryonic stem cells in preclinical models of macular degeneration

Human embryonic stem cell-derived retinal pigment epithelium in patients with age-related macular degeneration and Stargardt's macular dystrophy: follow-up of two open-label phase 1/2 studies

ARPE-19, a human retinal pigment epithelial cell line with differentiated properties

Modeling retinal degeneration using patient-specific induced pluripotent stem cells

Generation of three-dimensional retinal tissue with functional photoreceptors from human iPSCs

P304

421-427

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1242/DMM.017236

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P5008

P577

2015-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

277345985

http://www.w3.org/2001/XMLSchema#string

P698

26035859

http://www.w3.org/2001/XMLSchema#string

P921

biomedical investigative technique

age related macular degeneration

P932

4415892

http://www.w3.org/2001/XMLSchema#string